EYPT logo

EyePoint Pharmaceuticals (EYPT) Book value

annual book value:

$336.50M+$70.18M(+26.35%)
December 31, 2024

Summary

  • As of today (June 17, 2025), EYPT annual book value is $336.50 million, with the most recent change of +$70.18 million (+26.35%) on December 31, 2024.
  • During the last 3 years, EYPT annual book value has risen by +$152.12 million (+82.50%).
  • EYPT annual book value is now at all-time high.

Performance

EYPT Book value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEYPTbalance sheet metrics

quarterly book value:

$298.40M-$38.10M(-11.32%)
March 31, 2025

Summary

  • As of today (June 17, 2025), EYPT quarterly book value is $298.40 million, with the most recent change of -$38.10 million (-11.32%) on March 31, 2025.
  • Over the past year, EYPT quarterly book value has increased by +$48.46 million (+19.39%).
  • EYPT quarterly book value is now -11.32% below its all-time high of $336.50 million, reached on December 31, 2024.

Performance

EYPT quarterly book value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEYPTbalance sheet metrics

Book value Formula

Book Value = Total Assets − Total Liabilities

EYPT Book value Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+26.4%+19.4%
3 y3 years+82.5%+78.9%
5 y5 years+3939.6%+1711.3%

EYPT Book value Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+249.2%-11.3%+421.1%
5 y5-yearat high+3939.6%-11.3%+7025.0%
alltimeall timeat high+8118.0%-11.3%+7187.4%

EYPT Book value History

DateAnnualQuarterly
Mar 2025
-
$298.40M(-11.3%)
Dec 2024
$336.50M(+26.4%)
$336.50M(+53.8%)
Sep 2024
-
$218.73M(-4.2%)
Jun 2024
-
$228.31M(-8.7%)
Mar 2024
-
$249.93M(-6.2%)
Dec 2023
$266.32M(+176.4%)
$266.32M(+354.3%)
Sep 2023
-
$58.62M(+2.4%)
Jun 2023
-
$57.26M(-27.0%)
Mar 2023
-
$78.39M(-18.7%)
Dec 2022
$96.37M(-47.7%)
$96.37M(-29.3%)
Sep 2022
-
$136.35M(-9.9%)
Jun 2022
-
$151.37M(-9.3%)
Mar 2022
-
$166.82M(-9.5%)
Dec 2021
$184.38M(+894.4%)
$184.38M(+98.8%)
Sep 2021
-
$92.75M(-13.2%)
Jun 2021
-
$106.86M(-7.6%)
Mar 2021
-
$115.71M(+524.1%)
Dec 2020
$18.54M(+122.6%)
$18.54M(+144.2%)
Sep 2020
-
$7.59M(+81.3%)
Jun 2020
-
$4.19M(-74.6%)
Mar 2020
-
$16.47M(+97.8%)
Dec 2019
$8.33M(-77.9%)
$8.33M(-47.7%)
Sep 2019
-
$15.94M(-43.5%)
Jun 2019
-
$28.21M(+41.9%)
Mar 2019
-
$19.88M(-58.3%)
Dec 2018
$37.63M(+222.0%)
-
Sep 2018
-
$47.70M(+308.2%)
Jun 2018
$11.69M(-12.4%)
$11.69M(+42.6%)
Mar 2018
-
$8.20M(-17.2%)
Dec 2017
-
$9.90M(+10.0%)
Sep 2017
-
$9.00M(-32.5%)
Jun 2017
$13.34M(-36.1%)
$13.34M(+6.6%)
Mar 2017
-
$12.51M(-15.3%)
Dec 2016
-
$14.76M(+2.2%)
Sep 2016
-
$14.45M(-30.8%)
Jun 2016
$20.88M
$20.88M(-21.4%)
Mar 2016
-
$26.55M(+84.1%)
Dec 2015
-
$14.42M(-23.4%)
DateAnnualQuarterly
Sep 2015
-
$18.82M(-19.4%)
Jun 2015
$23.37M(+56.6%)
$23.37M(-16.1%)
Mar 2015
-
$27.85M(-13.7%)
Dec 2014
-
$32.27M(-9.9%)
Sep 2014
-
$35.80M(+139.9%)
Jun 2014
$14.92M(+93.8%)
$14.92M(-18.7%)
Mar 2014
-
$18.35M(+45.6%)
Dec 2013
-
$12.60M(-11.5%)
Sep 2013
-
$14.24M(+84.9%)
Jun 2013
$7.70M(-43.5%)
$7.70M(-31.5%)
Mar 2013
-
$11.24M(-18.6%)
Dec 2012
-
$13.81M(-14.6%)
Sep 2012
-
$16.16M(+18.5%)
Jun 2012
$13.64M(-63.6%)
$13.64M(-12.3%)
Mar 2012
-
$15.55M(-12.6%)
Dec 2011
-
$17.79M(-49.5%)
Sep 2011
-
$35.23M(-5.9%)
Jun 2011
$37.43M(+13.3%)
$37.43M(+1.2%)
Mar 2011
-
$36.99M(+18.9%)
Sep 2010
-
$31.11M(-5.9%)
Jun 2010
$33.04M(+40.4%)
$33.04M(+68.8%)
Mar 2010
-
$19.58M(-12.9%)
Dec 2009
-
$22.48M(+4.2%)
Sep 2009
-
$21.57M(-8.4%)
Jun 2009
$23.54M(-21.7%)
$23.54M(+11.6%)
Mar 2009
-
$21.09M(-3.2%)
Dec 2008
-
$21.79M(-20.2%)
Sep 2008
-
$27.32M(-9.2%)
Jun 2008
$30.08M(-64.0%)
$30.08M(-66.3%)
Mar 2008
-
$89.16M(-5.8%)
Dec 2007
-
$94.67M(-6.7%)
Sep 2007
-
$101.50M(+21.5%)
Jun 2007
$83.55M(-35.7%)
$83.55M(+26.2%)
Dec 2006
-
$66.20M(-49.1%)
Jun 2006
$129.96M(+114.7%)
$129.96M(+114.7%)
Jun 2005
$60.52M(+136.4%)
$60.52M(+136.4%)
Jun 2004
$25.60M(+525.3%)
$25.60M(+525.3%)
Jun 2003
$4.09M(-10.5%)
$4.09M
Jun 2001
$4.57M
-

FAQ

  • What is EyePoint Pharmaceuticals annual book value?
  • What is the all time high annual book value for EyePoint Pharmaceuticals?
  • What is EyePoint Pharmaceuticals annual book value year-on-year change?
  • What is EyePoint Pharmaceuticals quarterly book value?
  • What is the all time high quarterly book value for EyePoint Pharmaceuticals?
  • What is EyePoint Pharmaceuticals quarterly book value year-on-year change?

What is EyePoint Pharmaceuticals annual book value?

The current annual book value of EYPT is $336.50M

What is the all time high annual book value for EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals all-time high annual book value is $336.50M

What is EyePoint Pharmaceuticals annual book value year-on-year change?

Over the past year, EYPT annual book value has changed by +$70.18M (+26.35%)

What is EyePoint Pharmaceuticals quarterly book value?

The current quarterly book value of EYPT is $298.40M

What is the all time high quarterly book value for EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals all-time high quarterly book value is $336.50M

What is EyePoint Pharmaceuticals quarterly book value year-on-year change?

Over the past year, EYPT quarterly book value has changed by +$48.46M (+19.39%)
On this page